lenvatinib plus pembrolizumab after progression on immune checkpoint inhibitors for metastatic rcc
Published 3 years ago • 271 plays • Length 5:14Download video MP4
Download video MP3
Similar videos
-
2:06
lenvatinib plus pembro for arcc - update on the clear study
-
10:06
lenvatinib and pembrolizumab compared to sunitinib for advanced renal cell carcinoma
-
1:22
discussing the phase ii study of lenvatinib/pembrolizumab in metastatic ccrcc
-
6:07
sequential use of immune checkpoint inhibitors in renal cell carcinoma
-
7:05
health-related quality of life with lenvatinib plus pembrolizumab for patients with advanced rcc
-
4:44
vegfr inhibitors with immune checkpoint inhibitors for advanced renal cancer
-
32:46
lenvatinib pembrolizumab in rcc, the clear trial with karine tawagi
-
0:59
combining lenvatinib & pembrolizumab for non-clear cell rcc: keynote-b61 study rationale
-
8:13
how to use lenvatinib capsule - explain uses,side effects,interactions
-
4:10
lenvima® (lenvatinib) plus everolimus in advanced renal cell carcinoma
-
5:09
recent advances in treating advanced kidney cancer
-
0:49
clear: lenvatinib and pembrolizumab in advanced renal cell carcinoma
-
2:32
len pembro metastatic clear cell renal cell carcinoma
-
6:25
contextualizing new data on checkpoint inhibitors for non-clear cell rcc
-
4:36
dr. van akkooi on crossover or rechallenge with pembrolizumab in patients with resected melanoma
-
0:49
immune checkpoint inhibition could be the future of renal cell carcinoma treatment
-
1:44
assessing lenvatinib with pembrolizumab in advanced renal cell carcinoma
-
7:27
cabozantinib plus immune checkpoint inhibitor versus cabozantinib monotherapy in mccrcc
-
6:05
leap-004: lenvatinib pembrolizumab for patients with advanced melanoma and confirmed progressi...
-
1:28
keynote-b61: first-line lenvatinib pembrolizumab in non-clear cell rcc
-
2:03
lesion responses to lenvatinib and pembrolizumab based on organ sites
-
2:21
lba41 - leap-005: phase ii study of lenvatinib plus pembrolizumab